Login / Signup
Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?
Marjolein de Bruin-Weller
Published in:
The British journal of dermatology (2020)
Keyphrases
</>
atopic dermatitis
clinical trial
phase ii
open label
double blind
phase iii
clinical evaluation